India: access to affordable drugs and the right to health.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades.BMC health services research · 2022
   Article
2. Non communicable disease multimorbidity and associated health care utilization and expenditures in India: cross-sectional study.BMC health services research · 2014
   Article
3. HIV as a chronic disease considerations for service planning in resource-poor settings.Globalization and health · 2011
   Article
4. Towards achievement of universal health care in India by 2020: a call to action.Lancet (London, England) · 2011
   Review

Corrections and comments

• Commented on by
  Towards universal health coverage in India.2011
• Erratum issued

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as